(Q37947688)

25 August 2017

title

Epidemiological findings of vascular risk factors in Alzheimer's disease: implications for therapeutic and preventive intervention (English)

1 reference

25 August 2017

0 references

1

1 reference

25 August 2017

publication date

1 November 2011

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

25 August 2017

published in

1 reference

25 August 2017

volume

11

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1593-1607

1 reference

Epidemiology of Alzheimer disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Alzheimer disease prevention: focus on cardiovascular risk, not amyloid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

A review of selected longitudinal studies on aging: past findings and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Secondhand smoke, vascular disease, and dementia incidence: findings from the cardiovascular health cognition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Smoking, dementia and cognitive decline in the elderly, a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Cigarette smoking and dementia: potential selection bias in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Alcohol, dementia and cognitive decline in the elderly: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Physical activity and Alzheimer disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Physical activity, diet, and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

The age-dependent relation of blood pressure to cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Risk of incident dementia in drug-untreated arterial hypertension: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Low diastolic pressure and risk of dementia in very old people: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Blood pressure and the risk for dementia: a double edged sword.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Body mass index, other cardiovascular risk factors, and hospitalization for dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Overweight in midlife and risk of dementia: a 40-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Midlife and late-life obesity and the risk of dementia: cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Adiposity indicators and dementia over 32 years in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

A life course of adiposity and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Cholesterol-modifying strategies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Mediterranean diet, Alzheimer disease, and vascular mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Adherence to a Mediterranean diet, cognitive decline, and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Food combination and Alzheimer disease risk: a protective diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Dietary factors and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Relation of higher folate intake to lower risk of Alzheimer disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Body mass index, dementia, and mortality in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Hyperhomocysteinemia and Alzheimer's disease: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

The effect of borderline diabetes on the risk of dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Accelerated progression from mild cognitive impairment to dementia in people with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Inflammatory proteins in plasma and the risk of dementia: the rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Inflammatory markers and the risk of Alzheimer disease: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Metabolic syndrome and dementia risk in a multiethnic elderly cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Metabolic syndrome and risk of dementia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Association of metabolic syndrome with Alzheimer disease: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Adiposity, type 2 diabetes, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Ankle-to-brachial index and dementia: the Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Arterial pulse wave velocity and cognition with advancing age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Carotid- intima media thickness is independently associated with cognitive decline. The INVADE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Coronary artery calcium, brain function and structure: the AGES-Reykjavik Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Epidemiological studies of the effect of stroke on incident dementia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Aggregation of vascular risk factors and risk of incident Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Predicting risk of dementia in older adults: The late-life dementia risk index

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Treatment of vascular risk factors is associated with slower decline in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Cerebral microbleeds: a guide to detection and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Silent brain infarcts: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Effect of infarcts on dementia in the Baltimore longitudinal study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Stroke and the risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Cognitive impairment risk: white matter hyperintensity progression matters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Neuropathological basis of magnetic resonance images in aging and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Risk of dementia in diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

AD brain pathology: vascular origins? Results from the HAAS autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Reducing the risk of dementia: efficacy of long-term treatment of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Duration of antihypertensive drug use and risk of dementia: A prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Chronic disease long-term drug prevention trials: lessons from the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Estrogen therapy and Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Timing of hormone therapy and dementia: the critical window theory revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Ginkgo biloba for prevention of dementia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Effects of Ginkgo biloba in dementia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Ginkgo biloba in Alzheimer's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Vascular risk factors and dementia: how to move forward?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Age-varying association between statin use and incident Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Age, neuropathology, and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

A life-course approach to the aetiology of late-onset dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Promising strategies for the prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Endpoints for trials in Alzheimer's disease: a European task force consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Report of the task force on designing clinical trials in early (predementia) AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Age-Varying Association Between Blood Pressure and Risk of Dementia in Those Aged 65 and Older: A Community-Based Prospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

The Effect of Age on the Association Between Blood Pressure and Cognitive Function Later in Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Atherosclerosis and risk for dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Unrecognized Myocardial Infarction in Relation to Risk of Dementia and Cerebral Small Vessel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

Heart Disease and Dementia: A Population-based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.11.146

21 January 2018

Identifiers

DOI

10.1586/ERN.11.146

1 reference

release_k7p6kbufv5huzmicveobkgqoki

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k7p6kbufv5huzmicveobkgqoki

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference